Aadi Bioscience, Inc.
Index- P/E- EPS (ttm)-2.98 Insider Own0.30% Shs Outstand21.27M Perf Week-2.18%
Market Cap307.60M Forward P/E- EPS next Y-2.53 Insider Trans0.00% Shs Float20.64M Perf Month4.32%
Income-62.60M PEG- EPS next Q-0.67 Inst Own63.00% Short Float / Ratio5.02% / 11.99 Perf Quarter-1.18%
Sales11.00M P/S27.96 EPS this Y-712.40% Inst Trans13.64% Short Interest1.04M Perf Half Y1.46%
Book/sh7.95 P/B1.58 EPS next Y12.20% ROA-40.20% Target Price42.50 Perf Year-32.38%
Cash/sh7.47 P/C1.68 EPS next 5Y- ROE-46.50% 52W Range11.00 - 21.15 Perf YTD-2.18%
Dividend- P/FCF- EPS past 5Y-1.30% ROI-77.90% 52W High-40.66% Beta1.24
Dividend %- Quick Ratio10.60 Sales past 5Y- Gross Margin89.90% 52W Low14.09% ATR0.48
Employees76 Current Ratio10.60 Sales Q/Q- Oper. Margin- RSI (14)45.97 Volatility3.82% 3.99%
OptionableNo Debt/Eq0.00 EPS Q/Q92.60% Profit Margin- Rel Volume0.41 Prev Close12.81
ShortableYes LT Debt/Eq0.00 EarningsNov 09 BMO Payout- Avg Volume86.44K Price12.55
Recom1.60 SMA20-1.04% SMA50-2.58% SMA200-6.72% Volume35,174 Change-2.03%
Jan-11-22Initiated Jefferies Buy $45
Oct-01-21Initiated Cowen Outperform
Sep-14-21Initiated Ladenburg Thalmann Buy $51
Sep-08-21Initiated Piper Sandler Overweight $45
Nov-17-22 08:00AM
Nov-09-22 08:00AM
Nov-08-22 04:00PM
Nov-03-22 08:00AM
Oct-27-22 08:00AM
08:01AM Loading…
Oct-12-22 08:01AM
Sep-22-22 04:01PM
Sep-01-22 08:00AM
Aug-10-22 08:00AM
Aug-04-22 06:21AM
Jul-28-22 08:30AM
Jun-23-22 08:00AM
Jun-01-22 08:00AM
May-31-22 08:00AM
05:10PM Loading…
May-26-22 05:10PM
May-18-22 07:00AM
May-12-22 08:32AM
May-09-22 08:00AM
May-04-22 08:00AM
Apr-28-22 05:07PM
Apr-18-22 08:00AM
Apr-08-22 01:09PM
Apr-01-22 05:13AM
Mar-31-22 02:45PM
Mar-17-22 07:00AM
Mar-01-22 07:00AM
Feb-25-22 04:41AM
Feb-23-22 07:00AM
04:30PM Loading…
Jan-04-22 04:30PM
Dec-28-21 09:38AM
Dec-23-21 12:38PM
Dec-21-21 09:38AM
Dec-16-21 09:38AM
Dec-08-21 09:38AM
Nov-27-21 06:01AM
Nov-23-21 04:22PM
Nov-15-21 08:00AM
Nov-13-21 01:35PM
Nov-10-21 07:00AM
Nov-09-21 08:00AM
Nov-01-21 04:05PM
Oct-25-21 08:00AM
Oct-22-21 08:00AM
Oct-19-21 05:22PM
Oct-06-21 08:00AM
Sep-20-21 08:30AM
Sep-13-21 08:00AM
Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, including tumor agnostic indications targeting specific genomic alterations that activate the mTOR pathway. The company was incorporated in 2007 and is headquartered in Pacific Palisades, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Desai NeilSee RemarksMar 18Sale20.073,55071,2341,915,543Mar 22 05:34 PM